Company / Book Value per Share
Dexcom Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.136
FY2025
5-year range
$4 / $21.25
FY2021-FY2025
Trend
+32.6%
vs FY2024
Sector context
#109 of 158
Health Care
What the data says
At $7.136, Dexcom's book value per share ranks #109 of 158 in the Health Care sector. Book Value per Share has increased for 3 consecutive years, from $4 in FY2022 to $7.136 in FY2025.
Based on SEC 10-K filings.
$7.136 in FY2025 with a 5-year CAGR of -15.1%.
Improved from $5.367 to $7.136 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +21.3%
- 5-Year CAGR
- -15.1%
- 10-Year CAGR
- -
Sector benchmark
#109 of 158 in Health CareTop 69% of 158This company $7.136 Sector average $48.175
▼
-85.2% below sector average
Key checks
Key Insights
- Dexcom's book value per share has grown for 3 consecutive years.
- 5-year CAGR of -15.1%, indicating a declining trend.
- In FY2025, book value per share increased 32.6% year-over-year.
- Ranks #109 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.136 | +32.6% |
| FY2024 | $5.382 | +0.3% |
| FY2023 | $5.367 | +34.2% |
| FY2022 | $4 | -81.2% |
| FY2021 | $21.25 | +31.6% |
| FY2020 | $16.149 | +67.6% |
| FY2019 | $9.635 | +26.4% |
| FY2018 | $7.624 | +191.6% |
| FY2017 | $2.615 | +52.4% |
| FY2016 | $1.716 | +57.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026